Back to Journals » International Journal of Nanomedicine » Volume 6

Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior

Authors Karavelidis, Karavas E, Giliopoulos, Papadimitriou, Bikiaris D

Published 24 November 2011 Volume 2011:6 Pages 3021—3032


Review by Single-blind

Peer reviewer comments 3

Vassilios Karavelidis1,2, Evangelos Karavas2, Dimitrios Giliopoulos1, Sofia Papadimitriou1, Dimitrios Bikiaris1
1Laboratory of Polymer Chemistry and Technology, Chemistry Department, Aristotle University of Thessaloniki, Thessaloniki, 2Pharmathen SA, Pharmaceutical Industry, Pallini Attikis, Attiki, Greece

Abstract: Four new polyesters based on 1,3-propanediol and different aliphatic dicarboxylic acids were used to prepare ropinirole HCl-loaded nanoparticles. The novelty of this study lies in the use of polyesters with similar melting points but different degrees of crystallinity, varying from 29.8% to 67.5%, as drug nanocarriers. Based on their toxicity to human umbilical vein endothelial cells, these aliphatic polyesters were found to have cytotoxicity similar to that of polylactic acid and so may be considered as prominent drug nanocarriers. Drug encapsulation in polyesters was performed via an emulsification/solvent evaporation method. The mean particle size of drug-loaded nanoparticles was 164–228 nm, and the drug loading content was 16%–23%. Wide angle X-ray diffraction patterns showed that ropinirole HCl existed in an amorphous state within the nanoparticle polymer matrices. Drug release diagrams revealed a burst effect for ropinirole HCl in the first 6 hours, probably due to release of drug located on the nanoparticle surface, followed by slower release. The degree of crystallinity of the host polymer matrix seemed to be an important parameter, because higher drug release rates were observed in polyesters with a low degree of crystallinity.

Keywords: biocompatible polyesters, nanoparticles, ropinirole, release, crystallinity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]